ArticleCurrent medicinal chemistry2025

HTB50-2 Inhibits Growth and Migration of Triple-negative Breast Cancer via FOSL2/FOXC1 Signaling Axis and Subsequent Ferroptosis.

Na Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.